Financhill
Sell
48

AMED Quote, Financials, Valuation and Earnings

Last price:
$91.90
Seasonality move :
7.37%
Day range:
$91.69 - $92.99
52-week range:
$82.15 - $98.95
Dividend yield:
0%
P/E ratio:
70.15x
P/S ratio:
1.29x
P/B ratio:
2.66x
Volume:
489.2K
Avg. volume:
341.3K
1-year change:
-0.98%
Market cap:
$3B
Revenue:
$2.3B
EPS (TTM):
$1.31

Earnings Data

Next earnings date for AMED
Apr 24
2025
Most recent earnings per share
-$0.62
Missed by $1.68
(Feb 26/2025)
Consensus Estimate
$1.06
(Feb 26/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

AMED Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $611.9M -- -- $1.36 --
04/24/2025 Q1 $596.3M -- -- $1.11 --
02/26/2025 Q4 $602.4M $598.1M -$0.62 $1.06 -$1.68
11/06/2024 Q3 $588.8M $587.7M $0.51 $1.17 -$0.66
07/24/2024 Q2 $581.8M $591.2M $0.98 $1.18 -$0.20
05/03/2024 Q1 $569.3M $571.4M $0.44 $1.01 -$0.57
02/16/2024 Q4 $567.7M $570.8M $0.59 $1.03 -$0.44
10/24/2023 Q3 -- -- $0.79 $1.07 -$0.28
07/26/2023 Q2 -- -- -$2.46 $1.09 -$3.55
05/03/2023 Q1 -- -- $0.77 $0.88 -$0.11
02/15/2023 Q4 -- -- $0.97 $0.98 -$0.01
10/26/2022 Q3 -- -- $0.79 $1.22 -$0.43
07/27/2022 Q2 -- -- $0.91 $1.23 -$0.32
04/27/2022 Q1 -- -- $0.97 $1.12 -$0.15
02/23/2022 Q4 -- -- $1.04 $1.18 -$0.14
11/02/2021 Q3 -- -- $1.37 $1.37 $0.00
08/04/2021 Q2 -- -- $2.43 $1.67 $0.76
04/28/2021 Q1 -- -- $1.50 -- --
02/25/2021 Q4 -- -- $1.36 -- --
10/28/2020 Q3 -- -- $2.16 -- --
07/28/2020 Q2 -- -- $1.04 -- --
05/06/2020 Q1 -- -- $0.96 -- --
02/18/2020 Q4 -- -- $0.83 -- --
10/29/2019 Q3 -- -- $1.03 -- --
07/31/2019 Q2 -- -- $1.02 -- --
04/30/2019 Q1 -- -- $0.95 -- --
02/27/2019 Q4 -- -- $0.84 -- --
10/29/2018 Q3 -- -- $0.96 -- --
07/31/2018 Q2 -- -- $0.98 -- --
05/07/2018 Q1 -- -- $0.79 -- --
02/27/2018 Q4 -- -- -$0.11 -- --
11/07/2017 Q3 -- -- $0.42 -- --
07/26/2017 Q2 -- -- $0.13 -- --
05/02/2017 Q1 -- -- $0.44 -- --
03/01/2017 Q4 -- -- $0.26 -- --
11/04/2016 Q3 -- -- $0.34 -- --
08/02/2016 Q2 -- -- $0.32 -- --
05/03/2016 Q1 -- -- $0.19 -- --
03/09/2016 Q4 -- -- $0.38 -- --
11/05/2015 Q3 -- -- $0.25 -- --
07/29/2015 Q2 -- -- $0.32 -- --

Amedisys Earnings Questions

  • How Much did Amedisys Generate in Revenue Last Quarter?

    Amedisys reported $598.1M worth of top line sales in its most recent quarter.

  • Did Amedisys Beat Earnings Last Quarter?

    Amedisys announced earnings per share of -$0.62 which represents a miss of analyst forecast a $1.06 per share.

  • Is Amedisys Profitable?

    Amedisys reported $253.4M that represents $7.65 per share over the last quarter.

  • What is the Analyst Consensus for Amedisys EPS Next Year?

    Amedisys's earnings are forecast to grow from $1.31 per share to $4.74 per share next year representing an increase of 263.68%.

  • When is Amedisys's Earnings Date?

    Amedisys's next earnings date is April 24, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Do I Need to Know About Alcoa Stock?
What Do I Need to Know About Alcoa Stock?

Alcoa (AA) is a global leader in aluminum production. Based…

Is ROOT Stock the Next Big Thing?
Is ROOT Stock the Next Big Thing?

Root Holdings (NASDAQ:ROOT) is the parent company of Root Insurance,…

Is Okta a Good Stock to Buy?
Is Okta a Good Stock to Buy?

Okta (NASDAQ:OKTA) is used by some of the largest firms…

Stock Ideas

Sell
37
Is AAPL Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 31x

Sell
37
Is MSFT Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 30x

Sell
31
Is NVDA Stock a Buy?

Market Cap: $2.3T
P/E Ratio: 32x

Alerts

Sell
45
RGC alert for Apr 5

Regencell Bioscience Holdings [RGC] is up 32.59% over the past day.

Sell
25
GDXU alert for Apr 5

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 27.33% over the past day.

Buy
76
SOXS alert for Apr 5

Direxion Daily Semiconductor Bear 3X Shares [SOXS] is up 23.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock